Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 2/20 | 0.60 |
| ▸ | CDC7 | O00311 | 2/20 | 0.60 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.60 |
| ▸ | CLK1 | P49759 | 1/20 | 0.60 |
| ▸ | GSK3B | P49841 | 1/20 | 0.60 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.60 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.60 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.60 |
| ▸ | MGLL | Q99685 | 4/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 7/20 | 0.40 |
| ▸ | ACACA | Q13085 | 7/20 | 0.40 |
| ▸ | FASN | P49327 | 1/20 | 0.39 |
| ▸ | SPR | P35270 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3329906 | 0.92 | PIM1 (0.61) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3327369 | 0.92 | PIM1 (0.61) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3329321 | 0.91 | PIM1 (0.60) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3329929 | 0.91 | PIM1 (0.55) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3329788 | 0.90 | PIM1 (0.61) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3331214 | 0.89 | PIM1 (0.53) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3328243 | 0.89 | PIM1 (0.64) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3330930 | 0.89 | PIM1 (0.57) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3330323 | 0.88 | PIM1 (0.63) | PIM1CDC7CSNK2A2CLK1GSK3B | |
| SCHEMBL3330418 | 0.88 | PIM1 (0.63) | PIM1CDC7CSNK2A2CLK1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8242129-B2 | 6-phenylpyrimidinones as PIM modulators | EXELIXIS, INC. (US) | 2012-08-14 | — | — | US | claimed |
| US-20100135954-A1 | 6-Phenylpyrimidinones as PIM Modulators | EXELIXIS, INC. (US) | 2010-06-03 | — | — | US | claimed |
| CN-102317266-A | 6-phenylpyrimidinones as PIM modulators | EXELIXIS INC | 2012-01-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100135954-A1 | 6-Phenylpyrimidinones as PIM Modulators | PIM1, PIM2, PIM3 | PIM1 1/4885CDC7 3813/4885CSNK2A2 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.